Revolution Medicines Correlations
| RVMD Stock | USD 37.91 0.69 1.85% |
The current 90-days correlation between Revolution Medicines and Relay Therapeutics is 0.54 (i.e., Very weak diversification). The correlation of Revolution Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Revolution Medicines Correlation With Market
Good diversification
The correlation between Revolution Medicines and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and DJI in the same portfolio, assuming nothing else is changed.
Revolution | Build AI portfolio with Revolution Stock |
Moving against Revolution Stock
| 0.63 | BTC | BTC Health | PairCorr |
| 0.49 | PTHL | Pheton Holdings Trending | PairCorr |
| 0.48 | ZOTA | Zota Health Care | PairCorr |
| 0.44 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.43 | CICHF | China Construction Bank | PairCorr |
| 0.42 | METROPOLIS | Metropolis Healthcare | PairCorr |
| 0.39 | MGRM | Monogram Orthopaedics | PairCorr |
| 0.36 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.36 | GILD | Gilead Sciences | PairCorr |
| 0.31 | JNJ | Johnson Johnson | PairCorr |
| 0.56 | NPEGF | Nippon Electric Glass Earnings Call This Week | PairCorr |
| 0.5 | F | Ford Motor Earnings Call This Week | PairCorr |
| 0.49 | MHO | MI Homes Earnings Call This Week | PairCorr |
| 0.47 | MNTHY | Minth Group Limited | PairCorr |
| 0.47 | MAIN | Main Street Capital | PairCorr |
| 0.47 | RLJ | RLJ Lodging Trust | PairCorr |
| 0.45 | IVZ | Invesco Plc | PairCorr |
| 0.45 | SRFM | Surf Air Mobility | PairCorr |
| 0.44 | DNN | Denison Mines Corp Aggressive Push | PairCorr |
Related Correlations Analysis
| 0.85 | 0.15 | 0.76 | 0.62 | 0.16 | RLAY | ||
| 0.85 | 0.04 | 0.9 | 0.41 | 0.03 | STOK | ||
| 0.15 | 0.04 | 0.02 | 0.15 | 0.06 | PLRX | ||
| 0.76 | 0.9 | 0.02 | 0.24 | 0.03 | BDTX | ||
| 0.62 | 0.41 | 0.15 | 0.24 | 0.16 | ARVN | ||
| 0.16 | 0.03 | 0.06 | 0.03 | 0.16 | PASG | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Revolution Stock performing well and Revolution Medicines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Revolution Medicines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RLAY | 2.97 | 0.42 | 0.02 | (0.39) | 3.75 | 6.00 | 16.42 | |||
| STOK | 2.51 | 0.67 | 0.10 | (1.12) | 3.03 | 7.04 | 16.87 | |||
| PLRX | 3.36 | 0.26 | 0.00 | (0.52) | 4.16 | 7.43 | 18.42 | |||
| BDTX | 3.67 | 1.07 | 0.20 | 31.70 | 3.40 | 9.03 | 18.23 | |||
| ARVN | 2.98 | (0.13) | 0.00 | 1.72 | 0.00 | 4.59 | 27.51 | |||
| PASG | 6.70 | 0.63 | 0.05 | (2.13) | 6.61 | 17.91 | 40.89 |
Revolution Medicines Corporate Management
| David Pompliano | Founding Officer | Profile | |
| Jack Anders | Chief Officer | Profile | |
| Erin Graves | Senior Relations | Profile | |
| Walter Reiher | Chief Officer | Profile | |
| Path FRCP | Pres RD | Profile | |
| Margaret JD | Chief Officer | Profile |